| Period Ending | Mar 29, 2013 | Dec 28, 2012 | Sep 28, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
354,266
|
345,585
|
338,533
|
326,476
| | Cost of Revenue | 48,191 | 43,790 | 51,270 | 49,477 | | |
Gross Profit
|
306,075
|
301,795
|
287,263
|
276,999
| |
|
Operating Expenses |
|
Research Development | 124,084 | 118,382 | 115,078 | 112,031 |
|
Selling General and Administrative | 120,212 | 123,316 | 108,811 | 110,662 |
|
Non Recurring | (148) | 64 | 57 | 43 |
|
Others | 3,791 | 3,772 | 3,876 | 3,643 |
|
|
|
Total Operating Expenses | 247,939 | 245,534 | 227,822 | 226,379 | | | |
Operating Income or Loss
|
58,136
|
56,261
|
59,441
|
50,620
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 2,175 | 5,369 | (131) | 3,669 |
|
Earnings Before Interest And Taxes | 60,311 | 61,630 | 59,310 | 54,289 |
|
Interest Expense | 9,262 | 8,902 | 8,737 | 8,566 |
|
Income Before Tax | 51,049 | 52,728 | 50,573 | 45,723 |
|
Income Tax Expense | (27,560) | (261,146) | (8,011) | 9,337 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 78,609 | 313,874 | 58,584 | 36,386 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
78,609
|
313,874
|
58,584
|
36,386
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
78,609
|
313,874
|
58,584
|
36,386
|
|